Denis Caputo joins CSafe life science sales team for Latin America
CSafe Global has announced that Denis Caputo has officially joined the company as director of life science sales – Latin America.
CSafe has been building its worldwide Life Science sales team more than a year and Caputo is the most recent addition in the Americas region.
“Denis is based in Miami and comes with more than 25 years of leadership and sales experience working in Central and South America,” said Boris Eterovic, CSafe Global’s senior director of life sciences – Americas. “His in-depth expertise in supply chain management and customer relations for the pharmaceutical industry across Latin America will provide CSafe customers an accomplished partner in solving their most difficult shipping challenges.”
Caputo has been part of the cold chain industry and life sciences for his entire career and held various business development roles all focused on Latin America. Most recently, he was with va-Q-tec managing Healthcare & Logistics business development in Mexico, Puerto Rico and Florida. As part of the CSafe team, Caputo is responsible for customers in Central and South America and the Caribbean.
“CSafe is committed to protecting life-saving treatments and medicines as they are transported around the world so patients can live better, longer lives,” said CSafe chief commercial officer, Seth Hertel. “We have seen considerable growth in the manufacture of temperature-controlled pharmaceuticals across Latin America in the last several years. It’s critical that we have someone highly experienced in the industry and able to understand the market differences to ensure we give our customers the solutions they need. I am confident Denis is the right person to help us do exactly that.”
You may also like:-
Kempegowda International Airport, Bengaluru (KIAB/ BLR Airport) processed 180,745 kg of pomegranates from April to August 2020, making it India’s leading airport for pomegranate exports.
In this arrangement, CHAMP will be the preferred partner in the roll-out and testing of any new technologies and innovations.
The next big challenge will be future proofing the logistics workforce through training and upskilling in increasingly technologically sophisticated operations.
The IATA appointed independent assessment focuses on the quality assurance processes, operational and technical innovation, risk management, and the preservation of all relevant shipment data along the entire logistics chain.
In order to tackle these challenges, airports will require significant hydrogen transport and refueling infrastructure to meet the needs of day-to-day operations.
Flight CX8800 will be operated by a reconfigured Boeing 777-300ER passenger aircraft instead of Cathay Pacific's go-to ultra-long-haul freighter, the Boeing 747-8.
As the operation has been organised by the Austrian Federal Ministry of Interior, in the framework of the Union Civil Protection Mechanism (UCPM), the costs for the transport are co- financed up to 75 per cent by the European Commission.
Freight volumes handled at Europe's fifth-largest air cargo hub, Leipzig/Halle Airport, grew significantly in August. The volume of air freight rose by 12.7 percent to approximately 109,048 tonnes.
In order to reduce its ecological footprint, DB Schenker has equipped the new Orleans building with the latest technologies such as LED lighting, and maintains its premises without chemicals.
Turkish Cargo increased its global market share to 5.4 per cent from 3.9 per cent by accomplishing a growth by 67 per cent within the first half of 2020 thanks to its special cargo operations it has been maintaining by building up a global air bridge.
It emphasises the company's desire to support its long-standing and more recent customers in the area by delivering local services, supported by its global network.
The expanded schedule will offer enhanced connectivity for customers travelling to Dubai and beyond to Emirates’ network of over 85 destinations.
Prof. Dr Wouter Dewulf and Prof. Dr Roel Gevaers from the University of Antwerp and Pharma.aero’s Frank Van Gelder share their views on how a weak supply chain can destroy the quality of the Covid-19 vaccine.